Multiple sclerosis damages the nervous system in ways that extend beyond the well-known motor and cognitive symptoms. It also impairs the autonomic nervous system, and this shows up clearly in heart rate variability measurements.
A 2025 meta-analysis combining 43 studies and 2,580 participants confirmed what smaller studies had suggested: MS patients show greater sympathetic dominance compared to healthy controls.
How Common is Autonomic Dysfunction in MS?
It depends on how you measure it. A 2015 meta-analysis found cardiac autonomic dysfunction (CAD) prevalence of:
- 42.1% when using one abnormal test as the threshold
- 18.8% when requiring two or more abnormal tests
What's consistent: about 50% of MS patients report orthostatic dizziness - that lightheaded feeling when standing up quickly.
Disability level matters. Patients with higher EDSS scores (more severe disability) have dramatically more autonomic symptoms - 67% for EDSS >4 compared to just 3% for EDSS <4.
Which HRV Parameters Are Affected?
A study of 34 relapsing-remitting MS patients found all major time-domain HRV parameters were significantly reduced compared to healthy controls:
- SDNN (p = 0.019)
- SDANN (p = 0.040)
- RMSSD (p = 0.026)
The researchers concluded: "MS causes cardiac autonomic dysfunction manifesting as long-term HRV abnormalities."
Progressive MS vs Relapsing-Remitting
The type of MS matters:
- Progressive MS shows increased sympathetic-parasympathetic ratio at rest and decreased parasympathetic parameters (HF, E/I ratio)
- Relapsing-Remitting MS shows reduced E/I ratio but less severe overall impairment
- Progressive MS patients had higher sympathovagal ratio than RRMS patients
The Fascinating HRV-Fatigue Connection
Fatigue affects up to 80% of MS patients and is often the most disabling symptom. Its biological causes remain poorly understood - until researchers started looking at HRV.
A 2022 review proposed that HRV and fatigue represent "two parallel pathways" of the same inflammatory processes:
- Inflammatory processes activate the neuroinflammatory reflex
- The vagus nerve signals this inflammation to the brainstem and hypothalamus
- This triggers mild "sickness behavior" - and fatigue is a core symptom
- HRV changes reflect this same vagal signaling
The evidence supports this theory:
- MS patients with fatigue show reduced parasympathetic HRV
- LF/HF ratio correlates with fatigue severity
- Severe fatigue is associated with stronger HRV reductions than mild fatigue
In other words, tracking your HRV might give you insight into your fatigue burden.
Why MS Damages Autonomic Function
Several mechanisms work together:
- Demyelination - MS lesions can affect autonomic pathways in the brainstem and spinal cord
- Axonal injury - Direct damage to nerve fibers controlling autonomic function
- Inflammatory processes - Chronic inflammation affects vagal signaling
- Psychological factors - Disease-related emotional distress compounds physiological damage
Interestingly, one study found HRV abnormalities occur independently of visible CNS lesion burden - suggesting the autonomic damage extends beyond what shows on MRI.
Treatment Implications: The Fingolimod Caution
Fingolimod (Gilenya) is a common MS medication that works by modulating S1P receptors. It has significant cardiac effects:
- Heart rate decreases 8-12 bpm within 4-5 hours of first dose
- AV conduction abnormalities in 7-13% of patients
- Symptomatic bradycardia in 0.6-2.1%
Baseline autonomic dysfunction may predict greater bradycardic responses. This is why cardiac monitoring during fingolimod initiation matters - especially for patients with pre-existing autonomic impairment.
Newer S1P modulators (siponimod, ozanimod) show improved cardiac safety profiles through selective receptor binding and dose titration strategies.
What Might Help
Given the HRV-fatigue connection, interventions that improve parasympathetic function may help with MS symptoms.
Deep breathing: Research suggests deep breathing may help MS fatigue by temporarily increasing parasympathetic activity. There's "entrainment" between respiratory rate and vagal tone - slow breathing increases vagal activity.
Yoga: Studies show yoga practices (which rely heavily on deep breathing) may be particularly helpful for MS-related fatigue.
HRV biofeedback: Theoretically promising given the HRV-fatigue link, though specific MS trials are limited.
Practical Implications
If you have MS:
- Expect sympathetic dominance as your baseline - elevated LF/HF ratios are common
- Track HRV trends especially during relapses - it may correlate with symptom burden
- Low HRV may indicate higher fatigue burden - the two seem to move together
- Consider deep breathing practices for fatigue management
- Discuss autonomic function with your neurologist before starting S1P modulators
Honest Caveats
- Prevalence varies widely (19-42%) depending on diagnostic criteria.
- Direct evidence for the fatigue-HRV-inflammation pathway remains weak - simultaneous measures haven't been done.
- No standardized protocols exist for evaluating autonomic dysfunction in MS.
- No studies have examined whether treating autonomic dysfunction actually reduces MS symptom burden.
- EDSS-HRV correlation is inconsistent across studies.
Sources
Mirtajaddini et al. (2025). Heart rate variability in people with multiple sclerosis: A systematic review and meta-analysis. Acta Neurologica Belgica.
Racosta et al. (2020). Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies. Journal of Clinical Medicine.
Adamec et al. (2011). Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis. Acta Neurologica Belgica.
Sander et al. (2022). Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes? Neurological Sciences.